Predictors of survival after trimodality therapy for esophageal adenocarcinoma: Analysis from the National Cancer Database.

被引：0
|
作者：
Eng, Oliver [1 ]
Nelson, Rebecca A. [1 ]
Chao, Joseph [1 ]
Erhunmwunsee, Loretta [1 ]
Raz, Dan [1 ]
Kim, Jae Y. [1 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.116
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
116
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Predictors of survival after trimodality therapy for esophageal adenocarcinoma a single institute experience
    Tahir, Mehmood
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] Disparities in survival after trimodality therapy for esophageal adenocarcinoma
    Eng, O. S.
    Nelson, R. A.
    Konstantinidis, I.
    Chao, J.
    Erhunmwunsee, L.
    Raz, D. J.
    Kim, J. Y.
    [J]. DISEASES OF THE ESOPHAGUS, 2018, 31 (09)
  • [3] Analysis of the effect of adjuvant therapy on overall survival for resected gallbladder adenocarcinoma using the National Cancer Database.
    Brauer, David G.
    Lim, Kian-Huat
    Doyle, Maria Majella
    Hawkins, William G.
    Chapman, William C.
    Fields, Ryan C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] Predictors of Postoperative Complications After Trimodality Therapy for Esophageal Cancer
    Wang, Jingya
    Wei, Caimiao
    Tucker, Susan L.
    Myles, Bevan
    Palmer, Matthew
    Hofstetter, Wayne L.
    Swisher, Stephen G.
    Ajani, Jaffer A.
    Cox, James D.
    Komaki, Ritsuko
    Liao, Zhongxing
    Lin, Steven H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (05): : 885 - 891
  • [5] Effect of Health Disparities on Refusal of Trimodality Therapy in Localized Esophageal Adenocarcinoma: A Propensity Score Matched Analysis of the National Cancer Database
    Salti, Isabella
    Petesch, Taylor
    Naffouje, Samer A.
    Kamarajah, Sivesh K.
    Dahdaleh, Fadi
    [J]. AMERICAN SURGEON, 2023, 89 (11) : 4644 - 4653
  • [6] Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinoma
    Mitchell, Kyle G.
    Feldman, Hope
    Milton, Denai R.
    Antonoff, Mara B.
    Hofstetter, Wayne L.
    Rice, David C.
    Vaporciyan, Ara A.
    Lin, Ruitao
    Thall, Peter F.
    Rajaram, Ravi
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [7] Adjuvant chemotherapy and overall survival in patients with node positive esophageal adenocarcinoma treated with neoadjuvant therapy and esophagectomy: A retrospective analysis using the National Cancer Database.
    Ajmani, Gaurav
    Hensing, Thomas A.
    Kim, Ki-Wan
    Krantz, Seth B.
    Prinz, Richard A.
    Talamonti, Mark S.
    Baker, Marshall
    Bentrem, David J.
    Roggin, Kevin K.
    Marsh, Robert de Wilton
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] Systemic therapy for advanced appendiceal adenocarcinoma: An analysis from the National Comprehensive Cancer Network (NCCN) database.
    Tejani, Mohamedtaki Abdulaziz
    ter Veer, Anna
    Milne, Dana
    Ottsesen, Rebecca
    Bekaii-Saab, Tanios S.
    Benson, Al Bowen
    Schrag, Deborah
    Shibata, Stephen
    Skibber, John Michael
    Weiser, Martin R.
    Wilkinson, Neal W.
    Cohen, Steven J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] Esophageal cancer in Hispanic patients:A demographic analysis of the National Cancer Database.
    Ricardo, Juan
    Conte, Jorge
    Alkayali, Talal
    Salem, Ahmed
    Huston, Jamie
    Shridhar, Ravi
    Meredith, Kenneth L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer.
    Oh, Patrick
    Zhang, Minsi
    Brady, Paul
    Sihag, Smita
    Molena, Daniela
    Ilson, David H.
    Janjigian, Yelena Yuriy
    Ku, Geoffrey Yuyat
    Wu, Abraham Jing-Ching
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345